Metabolic Bone Diseases Clinical Study Group
The Metabolic bone disease CSG is chaired by Professor David
M Reid, Professor of Rheumatology at the University of
Aberdeen.
Annual report 2009
For more information on the recent activities of the Metabolic
bone disease CSG
please read the latest annual
report.
Steering group
A steering group for the metabolic bone disease CSG has been established whose
members are:
| Member |
Institution |
| Professor Juliet Compston |
University of Cambridge |
| Professor Cyrus Cooper |
Universities of Southampton & Oxford |
| Professor Richard Eastell |
University of Sheffield |
| Professor Roger Francis |
University of Newcastle (Vice-Chair) |
| Professor David Marsh |
University College London |
| Mrs Jean Nunn |
Lay Member |
| Dr Dani Preedy |
University of Southampton |
| Professor Stuart Ralston |
University of Edinburgh |
| Mr Mark Wilkinson |
University of Sheffield |
They provide a variety of expertise stretching across the entire
spectrum of metabolic bone diseases including post-menopausal
osteoporosis, secondary osteoporosis, Paget’s disease and rare
metabolic bone disorders.
Dr Dani Preedy previously of the National Osteoporosis Society and now
working for the National Institute of Health: Efficacy and
Evaluation Programme represents non-Arthritis Research UK funders
perspectives.
As needed the panel will be enhanced by others co-opted in to
provide expertise in additional speciality areas such as
orthopaedics or pharmacology.
Group meetings
The Steering Group held their first face-to-face meeting on 31st
January 2008 at the Novartis Foundation in London. The main aim of
that meeting was to reach an initial consensus on some of the 'Big
Questions' that need to be answered in the Bone arena,
including:
- The need for vitamin D testing and supplementation in
Osteoporosis Management
- How it is best to cost-effectively monitor treatment for
patients with metabolic bone disease
- How long should bisphosphonates be used in the treatment of
osteoporosis?
Strategy
Read the strategy.
A shortlist of questions has been circulated to a large number
of individual Research Group Members who will score the importance
of the research questions. The Research Group Members will be
self-nominated as having taken part in clinical studies or advising
on clinical research needs in Bone disease. If you wish to become a
member of the Research Group please email the chair at csg-metabolicbone@arthritisresearchuk.org
.
In addition to helping scope some of the big questions in Bone
Disease Research, members of the Research Group will receive a
regular email update of new contents on this website and will
potentially be invited to consider participation in commercial or
non-commercial clinical trials. Membership is free and will be
advertised at UK Bone meetings in 2008. Interest in membership will
also be sought through the Health Partners Forum of the
National Osteoporosis Society which
includes representative from the British Society of
Rheumatology, British Orthopaedic Association &
the UK division of the International Society for Fracture
Repair, British Endocrine Society,
British Geriatrics Society, British Society for Skeletal
Radiologists and the Bone Research Society. Articles will
be published on the work of the Research Group in Society
newsletters.
The Research Group chair will work with other research groups
chairs to involve pharmaceutical companies, and fund giving bodies
such as the Medical Research Council and Wellcome Trust thus
identifying further research needs and potential funding
opportunities. Liaison with UK
Clinical Research Network – Comprehensive Local Network will be
a key activity of the group and in addition contacts are being
established with similar emergent networks in Scotland via the
Scottish Executive Chief Scientist’s Office, Wales and Northern
Ireland.
Until a full clinical research strategy for Bone Disease studies
in the UK can be completed, Arthritis Research UK will
funnel applications for clinical research in Bone Disease via the
Steering Group for advice as to how the study matches the
developing strategy and thereafter, if appropriate, the project
will be sent for International Peer Review as normal.
Questionnaire - prioritising research proposals
The Metabolic Bone Disease CSG still wishes to seek your help in
drawing up the research proposals and prioritising them. If you are
willing to help with this process, please complete the questionnaire and
return to David Reid by email/fax/post.
Contact details
For all enquiries and additional information, please
contact:
Professor David Reid,
School of Medicine,
University of Aberdeen,
Foresterhill, Aberdeen, AB25 2ZD
csg_metabolicbone@arthritisresearchuk.org
Tel.: 01224 551154, Fax.: 01224 554761